期刊文献+

ⅠB~ⅡB期宫颈癌盆腔淋巴结转移的影响因素分析 被引量:7

Analysis of Influencing Factors Associated with Pelvic Lymph Node Metastasis in Stage Ⅰ B to Ⅱ B Cervical Cancer
下载PDF
导出
摘要 目的:探讨ⅠB~ⅡB期宫颈癌盆腔淋巴结转移的影响因素。方法:回顾性分析630例行手术治疗的ⅠB~ⅡB期宫颈癌患者的临床资料,了解盆腔淋巴结的转移情况,采用χ2检验、Mann-WhitneyU检验和多因素Logistic回归对宫颈癌盆腔淋巴结转移影响因素进行分析。结果:总体盆腔淋巴结转移率为27.9%(176/630),转移淋巴结754枚,其中74.8%(564/754)分布于宫旁/闭孔区。单因素分析表明,临床分期、细胞分化、宫体受累、脉管间隙受累、宫颈间质浸润深度、鳞状细胞癌抗原(SCC-Ag)和癌抗原125(CA125)水平与盆腔淋巴结转移相关(均P<0.05)。多因素分析表明,低细胞分化(OR=3.874,95%CI:1.100~13.646,P=0.035)、深1/3宫颈间质浸润(OR=2.735,95%CI:1.675~4.466,P<0.001)和脉管间隙受累(OR=73.822,95%CI:22.304~244.336,P<0.001)是盆腔淋巴结转移的独立危险因素。结论:宫颈癌盆腔淋巴结转移以宫旁/闭孔区最易受累,低细胞分化、深宫颈间质浸润、脉管间隙受累发生盆腔淋巴结转移风险较高,在临床治疗中,应确保宫旁切除范围,并实施系统性淋巴结清扫。 Objective:To investigate the influencing factors associated with pelvic lymph node metastasis(PLNM)in stageⅠB toⅡB cervical cancer.Methods:Clinical data of 630 patients with stageⅠB toⅡB cervical cancer treated with surgery were retrospectively studied.The PLNM condition of each patient was abstracted and the influencing factors of PLNM were analyzed byχ2,Mann-Whitney U test and multivariate logistic regression analysis.Results:27.9%(176/630)patients had PLNM.Among 754 metastatic lymph nodes,74.8%(564/754)of them were located in parametrial/obturator region.Result of univariate analysis suggested clinical stage,cell differentiation,uterine involvement,lymphovascular space invasion(LVSI),depth of stromal invasion,the level of SCC-Ag and CA125 were associated with PLNM(both P<0.05).The multivariate analysis suggested low cell differentiation(OR=3.874,95%CI:1.100-13.646,P=0.035),deep 1/3 stromal invasion(OR=2.735,95%CI:1.675-4.466,P<0.001)and LVSI(OR=73.822,95%CI:22.304-244.336,P<0.001)were the independent risk factors of PLNM.Conclusions:Parametrial/obturator region are the most vulnerable areas of PLNM in cervical cancer.Patients with low cell differentiation,deep stromal invasion and LVSI are associated with a high risk of PLNM.In clinical treatment,surgeon should ensure the parametrial-excision range,and the implementation of systemic lymphadenectomy.
作者 关德凤 陈思璐 陈葛舒逸 吕晓 杨永秀 GUAN De-feng;CHEN Si-lu;CHEN Ge-shuyi;LYU Xiao;YANG Yong-xiu(The First Clinical Medical College of Lanzhou University,Lanzhou 730000,China;Department of Obstetrics and Gynecology,The First Hospital of Lanzhou University,Gansu Key Laboratory of Gynecologic Oncology,Lanzhou 730000,China)
出处 《国际妇产科学杂志》 CAS 2019年第4期462-465,共4页 Journal of International Obstetrics and Gynecology
基金 国家自然科学基金(81801419) 兰州大学创新创业项目(20180060077) 兰州大学第一临床医学院卓越计划(20180060072)
关键词 宫颈肿瘤 淋巴结 淋巴转移 细胞分化 肿瘤侵润 Uterine cervical neoplasms Lymph nodes Lymphatic metastasis Cell differentiation Neoplasm invasiveness
  • 相关文献

参考文献2

二级参考文献24

  • 1Xin-Wu Cui,Christian Jenssen,Adrian Saftoiu,Andre Ignee,Christoph F Dietrich.New ultrasound techniques for lymph node evaluation[J].World Journal of Gastroenterology,2013,19(30):4850-4860. 被引量:26
  • 2Jemal A,Bray F,Center MM,et al. Global cancer statistics [J]. CA Cancer J Clin, 2011,61 (2) : 69-90.
  • 3Oharak K, Sugahara S, Kageik K, et al. Retrospective comparison of clinical outcome between radiotherapy alone and surgery plus postoperative radiotherapy in the treatment of stages I B- IIB cervical squamous cell carcinoma [J]. Radiat Med, 2004,22 ( 1 ) : 42- 48.
  • 4Ghaemmaghami F, Saleh-Gargari S, Sahebdel B, et al. Risk factors and clinical aspects of recurrent invasive cervical carcinoma[J]. J Obstet Gynecol India,2012, 62(6):674-678.
  • 5Angioli R, Plotti F, Montera R, et al. Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer[J]. Gynecol Oncol, 2012,127 (2) : 290-296.
  • 6Yamashita H,Okuma K,Kawana K,et al. Comparison betweenconventional surgery plus postoperative adjuvant radiotherapy and concurrent chemoradiation for FIGO stage ]1 B cervical carcinoma:a retrospective study[J]. Am J Clin Oncol, 2010,33 (6) : 583-586.
  • 7Vizza E,Pellegrino A,Milani R,et al. Total laparoscopic radical hysterectomy and pelvic lymphadenectomy in locally advanced stage I B2-11 B cervical cancer patients after neoadjuvant chemotherapy[J]. Eur J Surg Oncol, 2011,37(4) : 364-369.
  • 8Uegaki K,Shimada M,Sato S,et al. Outcome of stage I B2- I] B patients with bulky uterine cervical cancer who underwent neoadjuvant chemotherapy followed radical hysterectomy[J]. Int J Clin Oncol, 2014,19(2) : 348-353.
  • 9Manci N,Marchetti C,Di Tucci C,et al. A prospective phase 11 study of topotecan (Hycamtin) and cisplatin as neoadjuvant chemotherapy in locallyadvanced cervical cancer [J]. Gynecol Oneol, 2011,122 (2) :285-290.
  • 10Ryu SY,Park SI,Nam BH,et al. Is adjuvant chemoradiotherapy overtreatment in cervical cancer patients with inter-mediate risk factors? [J]. Int J Radiat Oncol Biol Phys, 2011,79(3 ) : 794-799.

共引文献19

同被引文献44

引证文献7

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部